News

"Antimicrobial resistance gets little media attention, but the statistics around the issue are startling," writes John Conrad ...
PM: Great scientists, such as Pasteur (of course), Einstein ... and he has been a lecturer in pharmaceutical and biotechnology industry seminars and in business schools for several years.
The UTI-Diag project, a groundbreaking multisectoral initiative, officially launches with key objectives to: (i) improve the ...
Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today ...
Press Release - Africa CDC's Platform for Harmonized Health Products Manufacturing (PHAHM), in collaboration with the Team ...
Sanofi has added to its vaccine pipeline with an agreement to acquire Austria's Origimm Biotechnology and its ... head of the Sanofi Pasteur vaccines division at the French drugmaker.
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today ...
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to ...
Phase 1 will begin in early April 2025 at the Clinical Investigation Centre of the University Hospital of Tours and, later in June, at the Cochin-Pasteur Clinical Investigation Centre in Paris ...